Evaluation of mTOR function by a gain-of-function approach

Yoichiro Ohne1, Terunao Takahara, Tatsuya Maeda

  • 1Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Insights

Gain-of-function analysis using hyperactive mammalian target of rapamycin (mTOR) mutants provides new insights into cell growth regulation. These tools reveal unexpected functions and regulatory mechanisms of the mTOR pathway in vivo.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian target of rapamycin (mTOR), a key regulator of cell growth, has primarily been studied using loss-of-function methods.
  • Previous understanding of mTOR's cellular functions relied on rapamycin inhibition or RNAi knockdown, limiting mechanistic insights.

Purpose of the Study:

  • To re-evaluate the physiological function and regulatory mechanisms of the mTOR pathway.
  • To utilize newly identified hyperactive mTOR mutants for gain-of-function analyses.
  • To investigate mTOR activation mechanisms and in vivo functions.

Main Methods:

  • Isolation of hyperactive mTOR mutants through genetic screening in yeast.
  • In vitro kinase activity assays of isolated mTOR mutants.
  • Expression of mTOR mutants in cells to assess substrate phosphorylation.
  • Gain-of-function analysis of mTOR pathway components.

Main Results:

  • Isolated mTOR mutants demonstrated enhanced kinase activity in vitro.
  • Exogenous expression of these mutants inhibited dephosphorylation of known mTOR substrates.
  • Gain-of-function studies confirmed some established mTOR functions.
  • Unexpected observations prompted a reconsideration of mTOR pathway regulation and function.

Conclusions:

  • Hyperactive mTOR mutants are valuable tools for dissecting mTOR pathway activation and in vivo roles.
  • These mutants offer a complementary approach to loss-of-function studies for a comprehensive understanding of mTOR.
  • Further investigation using these tools is crucial for elucidating complex mTOR regulatory networks and physiological significance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...